In vivo, in vitro and pharmacologic models of Parkinson's disease
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
30433804
DOI
10.33549/physiolres.933895
PII: 933895
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- modely nemocí na zvířatech * MeSH
- otrava MPTP chemicky indukované genetika metabolismus patologie MeSH
- oxidopamin toxicita MeSH
- Parkinsonova nemoc genetika metabolismus patologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- oxidopamin MeSH
Parkinson's disease (PD), which is the second most common neurodegenerative disorder after Alzheimer's disease, is firstly defined after James Parkinson's report. It carries motor symptoms such as resting tremor, bradykinesia and rigidity of skeletal muscle and freezing of gait. Furthermore, non-motor symptoms such as cognitive and behavioral problems, besides sensory impairments are seen in the patients. However, they may also suffer from sleep disorders or autonomic dysfunction. Although there are some medications in order to symptomatic management, but unfortunately, scientist could not have found exact approaches to cure this disease. Hence, producing a model which can express the most pathophysiologic and behavioral aspects of the disease is a desire. In this paper, we aimed to describe the different models of Parkinson's disease in brief.
Citace poskytuje Crossref.org